D. Sprengers
About
In The Last Decade
D. Sprengers
27 papers receiving 553 citations
Peers
Comparison fields: 5 of 68
- Hepatology 467
- Epidemiology 429
- Surgery 176
- Gastroenterology 77
- Pulmonary and Respiratory Medicine 43
Countries citing papers authored by D. Sprengers
This map shows the geographic impact of D. Sprengers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Sprengers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Sprengers more than expected).
Fields of papers citing papers by D. Sprengers
This network shows the impact of papers produced by D. Sprengers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Sprengers. The network helps show where D. Sprengers may publish in the future.
Co-authorship network of co-authors of D. Sprengers
This figure shows the co-authorship network connecting the top 25 collaborators of D. Sprengers. A scholar is included among the top collaborators of D. Sprengers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Sprengers. D. Sprengers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 8 | |
| 4 | 20 | |
| 5 | Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines. | 6 |
| 6 | A pilot observational survey of hepatitis C in Belgium. | 8 |
| 7 | The HepCar registry: report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium. What is daily practice in HCC? | 8 |
| 8 | Guidelines for the management of chronic hepatitis C in patients infected after substance use. | 3 |
| 9 | Improvement in liver histology after 3 years of E1 therapeutic vaccination in 23 patients with chronic hepatitis C | 2 |
| 10 | 102 | |
| 11 | Hepatitis C: screening, treatment and prevention practical guidelines. | 5 |
| 12 | 35 | |
| 13 | 32 | |
| 14 | 23 | |
| 15 | 49 | |
| 16 | 181 | |
| 17 | 12 | |
| 18 | RANDOMIZED TRIAL OF LONGTERM SCLEROTHERAPY FOR VARICEAL REBLEEDING USING THE SAME PROTOCOL TO TREAT REBLEEDING IN ALL PATIENTS - FINAL REPORT | 1 |
| 19 | Assessment of bleeding risk in chronic liver disease | 2 |
| 20 | 18 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.